Non-GAAP diluted EPS from continuing operations1
13.4% Five-year CAGR1,2
Non-GAAP Operating Earnings1 (in millions)
12.0% Five-year CAGR1,2
Dividends per share
14.7% Five-year CAGR2
1Click here for a reconciliation of the differences between the non-GAAP and GAAP financial measures.
2Reflects growth between FY12 and FY16, using FY11 as a base.
July 6, 2015
DUBLIN, Ohio, July 6, 2015 /PRNewswire/ -- Cardinal Health today announced the completion of the acquisition of The Harvard Drug Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, THDG was owned by Court Square Capital Partners.
October 4, 2015
DUBLIN, Ohio, Oct. 4, 2015 /PRNewswire/ -- Cardinal Health today announced that it has completed the acquisition of Johnson & Johnson's Cordis business, a global leader in cardiology and endovascular devices, for $1.944 billion.
November 19, 2015